Maplight Therapeutics, Inc. · NASDAQ:MPLT
Hanson Kristopher sold 13,917 Maplight Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Hanson Kristopher (General Counsel) sold 13,917 Maplight Therapeutics, Inc. shares at an average US$30.13 for US$419K under a trading plan, leaving 162,331 shares. Filed May 11, 2026 (Form 4).
- Sold
- 13,917 shares
- Price
- US$30.13 average (US$27.61 to US$30.56)
- Value
- US$419K
- Holding after
- 162,331 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Voting Common Stock | Sale | 284 | US$27.61 | 175,964 | Direct |
| May 11, 2026 | Voting Common Stock | Sale | 846 | US$28.70 | 175,118 | Direct |
| May 11, 2026 | Voting Common Stock | Sale | 6,979 | US$30.04 | 168,139 | Direct |
| May 11, 2026 | Voting Common Stock | Sale | 5,808 | US$30.56 | 162,331 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Hanson Kristopher
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Hanson Kristopher · Sep 18, 2026
- Form 4 · Hanson Kristopher · Aug 19, 2026
- Form 4 · Hanson Kristopher · Jul 17, 2026
- Form 4 · Hanson Kristopher · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026